New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

The community is invited to learn about their brain health during a free month-long webinar series every Thursday to spread ...

Tommy Williams maintained his sister is well. "I believe further tests need to be taken because right now she's not sounding ...

Wisconsin's Alzheimer's Association hosted a special Black History Month event Tuesday, addressing Black Americans living with Alzheimer's and other dementia. The event was all about ...

Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.

Some two years into Leqembi’s launch, Eisai continues to go all-in on its Alzheimer’s disease-fighting antibody, which the ...

Charleson, who starred as Monica Quartermaine on 'General Hospital' and was the longest-tenured cast member on the soap opera ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms ...

Thomas Cooper’s parents hoped the oxygen therapy he was receiving at a facility in Troy, Michigan, would help his sleep apnea ...